Precipio Reports Q1 2026 Earnings: Revenue Growth and Adjusted EBITDA Decline
Precipio (PRPO) reported total revenue of $6.71 million for Q1 2026, up over 30% year-over-year but flat sequentially from the previous quarter. Pathology revenue increased to $6 million while product revenue declined due to a customer order shift. Adjusted EBITDA turned negative at -$200,000 compared to +$960,000 in Q4.
Topics: adjusted_ebitda cash_flow gross_margin revenue